Directs the commissioner of the office of alcoholism and substance abuse services to establish a program for individuals to receive free drug test strips to detect the presence of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants; directs the commissioner of the office of alcoholism and substance abuse services, in cooperation with the commissioner of the department of health, to develop and conduct a public awareness and educational campaign on the dangers of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants.

The bill requires New York's office of alcoholism and substance abuse services to create a program that provides free drug test strips. These strips will help people check for harmful substances like medetomidine, benzodiazepine, and nitazenes in their drugs. Additionally, the bill calls for a public awareness campaign about the dangers of these substances.

Supporters of the bill would highlight its proactive approach to combating drug-related harm by providing individuals with the tools they need to test their drugs for dangerous contaminants. They would emphasize the importance of education and awareness in helping to prevent overdoses and protect public health.

Critics may argue that the bill could inadvertently encourage drug use by providing a false sense of security through testing. They might also express concerns that the focus on specific substances could divert attention from broader addiction treatment and prevention efforts.